Safety study of JMT206 injection in healthy volunteers
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You weigh at least 110 pounds (50 kg) if male or 99 pounds (45 kg) if female, with a BMI between 19 and 28.
- You are in generally good health, with normal test results for your heart, lungs, blood, and urine.
- You agree to use effective birth control or remain abstinent during the study and for 6 months after the last dose.
- You have not taken any prescription or over-the-counter medications or herbal supplements in the past 4 weeks.
- You do not smoke more than 5 cigarettes a day and can avoid tobacco during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This study tests a new medicine called JMT202 for the first time in humans. It aims to see how safe the drug is and how the body processes it, in healthy volunteers.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.